Stocks in News: INDIGO, HPCL, CARBORUNDUM, AIA ENG, MANKIND, JSW STEEL, DR. REDDY
MAINBOARD IPO CALENDER
| Company | Open | Close | Price (Rs) |
| Concord Biotech | Aug 4 | Aug 8 | 705-741 |
| SBFC Finance | Aug 3 | Aug 7 | 54-57 |
Ahmedabad, 2 August
Indigo: Revenue at Rs 16,683 crore versus poll of Rs 16,025 crore, Net profit at Rs 3090 crore versus poll of Rs 2201 crore (Positive)
Fusion Micro: Net profit at Rs 120.0 cr vs Rs 75.0 cr, NII at Rs 294.0 cr vs Rs 184.0 cr (YoY) (Positive)
IOB: Net profit at Rs 500.0 cr vs Rs 392.0 cr, NII at Rs 2322.0 cr vs Rs 1754.0 cr (YoY) (Positive)
Hind Petro: Net profit of ₹6,203.9 cr vs poll of ₹5,697 cr, Revenue of ₹1.12 lk cr vs poll of ₹1.02 lk cr (Positive)
NH: Net profit at Rs 184.0 cr vs Rs 111.0 cr, Revenue at Rs 1233.0 cr vs Rs 1033.0 cr (YoY) (Positive)
Prataap: Net profit at Rs 13.0 cr vs loss Rs 10.0 cr, Revenue at Rs 388.0 cr vs Rs 383.0 cr (YoY) (Positive)
Kewal Kiran: Net profit at Rs 34 cr vs Rs 22.0 cr, Revenue at Rs 178.0 cr vs Rs 155.0 cr (YoY) (Positive)
Pricol: Net profit at Rs 32 cr vs Rs 21.0 cr, Revenue at Rs 522.0 cr vs Rs 434.0 cr (YoY) (Positive)
Carborundum: Net profit at Rs 113.0 cr vs Rs 78.0 cr, Revenue at Rs 1203.0 cr vs Rs 1140.0 cr (YoY) (Positive)
Amruntanjan: Net profit at Rs 7 cr vs Rs 4.0 cr, Revenue at Rs 78.0 cr vs Rs 71.0 cr (YoY) (Positive)
AIA Eng: Net profit at Rs 272 cr vs Rs 190 cr, Revenue at Rs 1240.0 cr vs Rs 1080.0 cr (YoY) (Positive)
Mankind: EBITDA at Rs 655.0 cr vs Rs 465.0cr, Revenue at Rs 2579.0 cr vs Rs 2180.0 cr (YoY) (Positive)
JSW Steel: Company ties up with Japan’s JFE Steel to produce CRGO-grade steel. (Positive)
Unichem: Ipca Laboratories has bought 2.35 crore equity shares in Unichem at an average price of Rs 402.25 per share (Positive)
Campus: ICICI Prudential Life Insurance Company has bought 25 lakh equity shares (Positive)
Lupin: Company gets USFDA nod to market generic skin treatment medication (Positive)
SME IPO CALENDAR
| Company | Open | Close | Price(Rs) | Lot | Exch. |
| Srivari Spices | Aug7 | Aug9 | 40-42 | 3000 | NSE |
| Yudiz Solu. | Aug4 | Aug8 | 162-165 | 800 | NSE |
| Sangani Hosp. | Aug4 | Aug8 | 37-40 | 3000 | NSE |
| Vinsys IT | Aug1 | Aug4 | 128 | 1000 | NSE |
| Oriana Power | Aug1 | Aug3 | 118 | 1200 | NSE |
Metropolis: Net profit at Rs 29.0 cr vs Rs 32.5 cr, Revenue at Rs 277.0 cr vs 292.0 cr (YoY) (Neutral)
Titan: Revenue at Rs 11,145 crore versus poll of Rs 10,300 crore, EBITDA at Rs 1103 crore versus poll of Rs 1280 crore (Neutral)
Sheela Foam: Net profit at Rs 43 cr vs Rs 42 cr, Revenue at Rs 645 cr vs Rs 701 cr (YoY) (Neutral)
Indostar: Net profit at Rs 31 cr vs Rs 45 cr, NII at Rs 90.0 cr vs Rs 102 cr (YoY) (Neutral)
SKF: Net profit at Rs 154 cr vs Rs 129 cr, Revenues at Rs 1150.0 cr vs Rs 1055.0 cr (YoY) (Neutral)
Dr Reddy’s: Mukesh Rathi resigns from the position of Chief Information Officer (Neutral)
L&T FH: Bain Capital offers 7.9 crore L&T Finance shares in block trade (Neutral)
Eicher: Royal Enfield total sales at 73,117 units vs estimates of 74,000 units (Neutral)
RITES: Appoints Krishna Gopal Agarwal as Chief Financial Officer w.e.f August 1 (Neutral)
Campus: Block deal for 80 lac shares likely in counter. Deal price band at Rs 295-300 per share as per media sources (Neutral)
Vardhman Steel: Net profit down 38.6% at ₹18.6 cr vs ₹30 cr, Revenue down 12.7% at ₹409.4 cr vs ₹469.2 cr (YoY) (Negative)
VIP Ind: Net Profit down 16.4% at ₹57.8 cr vs ₹69.1 cr, Revenue up 7.7% at ₹636.1 cr vs ₹590.6 cr (YoY) (Negative)
GUJGAS: Profit at Rs 215 crore versus poll of Rs 348 crore, Revenue at Rs 3781 crore versus poll of Rs 4019 crore (Negative)
Bliss Pharma: Net profit down 48% at Rs 14.4 cr vs Rs 27.5 cr, Revenue up 16% at Rs 159.5 cr vs Rs 188.7 cr (YoY) (Negative)
Indostar: Net profit at Rs 31 cr vs Rs 45 cr, NII at Rs 90.0 cr vs Rs 102 cr (YoY) (Negative)
Dhanuka: Net profit at Rs 32 cr vs Rs 49 cr, Revenue at Rs 369.0 cr vs Rs 393 cr (YoY) (Negative)
Vedanta: Twinstar expected to sell 16 crore shares of the company via block deals (Negative)
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)
